LGNDD Insider Trading Activity and SEC Form 4 Filings
LGNDD insider trading summary
No open-market insider purchases or sales of Ligand Pharmaceuticals Inc (LGNDD) have been reported on SEC Form 4 in the past 12 months.
Latest LGNDD insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 11, 2011 | John W Kozarich | Director | Buy | $12K (1,000 @ $11.79) |
| Nov 10, 2011 | Jason Aryeh | Director | Buy | $11K (1,000 @ $11.01) |
| Nov 10, 2011 | Jason Aryeh | Director | Buy | $11K (1,000 @ $10.90) |
| Nov 10, 2011 | Sunil Patel | Director | Buy | $9K (800 @ $11.11) |
| Nov 10, 2011 | Sunil Patel | Director | Buy | $19K (1,700 @ $11.11) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.